ADVANCED PANCREATIC CANCER
Clinical trials for ADVANCED PANCREATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED PANCREATIC CANCER trials appear
Sign up with your email to follow new studies for ADVANCED PANCREATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy targets hard-to-treat pancreatic cancer
Disease control Recruiting nowThis early-phase study tests a new combination therapy for advanced pancreatic cancer. It uses two types of immune cells—dendritic cells (DCs) and CAR-T cells—both designed to target a protein called Claudin18.2 found on tumors. The goal is to see if this approach is safe and can…
Matched conditions: ADVANCED PANCREATIC CANCER
Phase: EARLY_PHASE1 • Sponsor: Hainan Cancer Hospital • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New combo therapy aims to slow advanced pancreatic cancer
Disease control Recruiting nowThis study tests a new drug called LM-108, given with other cancer drugs, in people with advanced pancreatic cancer. The goal is to see if the combination is safe and can help slow the cancer's growth. About 72 adults will take part, and the study will measure side effects and ho…
Matched conditions: ADVANCED PANCREATIC CANCER
Phase: PHASE1, PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated May 14, 2026 12:01 UTC
-
Virus injection fights advanced pancreatic cancer in new trial
Disease control Recruiting nowThis early-phase trial tests a modified virus (hV01) that is injected directly into tumors to fight advanced pancreatic cancer. The study will enroll 12 adults whose cancer has not responded to standard treatments. The main goal is to see if the virus can shrink tumors and contro…
Matched conditions: ADVANCED PANCREATIC CANCER
Phase: PHASE2 • Sponsor: Hangzhou Converd Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:52 UTC
-
Personalized medicine hope for pancreatic cancer patients
Knowledge-focused Recruiting nowThis study aims to find genetic changes in the tumors of 750 people with advanced or metastatic pancreatic cancer. By identifying these changes, doctors hope to match patients with targeted treatments that may work better for them. The study does not test a new drug but collects …
Matched conditions: ADVANCED PANCREATIC CANCER
Phase: NA • Sponsor: Centre Leon Berard • Aim: Knowledge-focused
Last updated May 07, 2026 18:40 UTC